PCR77 Exploring Alternative Methods to Quantify Patient Preferences in Rare Neuromuscular Disorders: A Case Study of the IMI-PREFER Project

Value in Health, vol. 27, pp. S519

Authors 8

1. Cathy Anne Pinto

   Merck & Co., Inc., Rahway, NJ, USA (United States)

   Affiliation as printed

   Merck & Co., Inc, rahway, NJ, USA

2. Alison M. Blain

   Newcastle University

   Affiliation as printed

   Newcastle University, Newcastle, Tyne and wear, UK

3. Vikas Soekhai

   Erasmus MC · Erasmus University Rotterdam

   Affiliation as printed

   Erasmus University Rotterdam/Erasmus MC-Erasmus University Medical Center Rotterdam, Rotterdam, Netherlands

4. Ian P. Smith Aachen Janssen Pharmaceuticals

   Janssen (Netherlands)

   Affiliation as printed

   Janssen Pharmaceuticals, Utrecht, Netherlands

5. Esther Wilhelmina de Bekker-Grob

   Erasmus University Rotterdam

   Affiliation as printed

   Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, South-Holland, Netherlands

6. Jane H. Newman

   Newcastle University

   Affiliation as printed

   Newcastle University, Newcastle, Tyne and wear, UK

7. G. Ardine de Wit

   University Medical Center Utrecht

   Affiliation as printed

   UMC Utrecht, Utrecht, CS, Netherlands

8. Gráinne S. Gorman

   Newcastle University

   Affiliation as printed

   Newcastle University, Newcastle, Tyne and wear, UK